Department of Biomedical Sciences, SNU

Faculty

Faculty

Research

Research Field
Keyword
Therapeutic antibody, Protein Engineering, Immune profiling with machine learning algorithm
Intensive Major

Publication

  1. Jo DH, Kim JH, Yang W, Kim H, Chang S, Kim D, Chang M, Lee K, Chung J, Kim JH.
  2. Anti-complement component 5 antibody targeting MG4 domain inhibits choroidal
  3. neovascularization. Oncotarget. 2017; 8(28):45506-45516. PubMed [journal] PMID:
  4. , PMCID: PMC5542204
  5. Heo K, Min SW, Sung HJ, Kim HG, Kim HJ, Kim YH, Choi BK, Han S, Chung S, Lee ES,
  6. Chung J, Kim IH. An aptamer-antibody complex (oligobody) as a novel delivery
  7. platform for targeted cancer therapies. Journal of controlled release : official
  8. journal of the Controlled Release Society. 2016; 229:1-9. PubMed [journal] PMID:
  9. Kim S, Kim H, Jo DH, Kim JH, Kim SR, Kang D, Hwang D, Chung J. Bispecific
  10. anti-mPDGFRβ x cotinine scFv-Cκ-scFv fusion protein and
  11. cotinine-duocarmycin can form antibody-drug conjugate-like complexes that exert
  12. cytotoxicity against mPDGFRβ expressing cells. Methods (San Diego, Calif.). 2018;
  13. PubMed [journal] PMID: 30292795
  14. Jin J, Park G, Park JB, Kim S, Kim H, Chung J. An anti-EGFR × cotinine bispecific
  15. antibody complexed with cotinine-conjugated duocarmycin inhibits growth of
  16. EGFR-positive cancer cells with KRAS mutations. Experimental & molecular
  17. medicine. 2018; 50(5):67. PubMed [journal] PMID: 29795377, PMCID: PMC5967348
  18. Lee HK, Lee Y, Kim H, Lee HE, Chang H, Nam KT, Jeong DH, Chung J. Screening of
  19. Pro-Asp Sequences Exposed on Bacteriophage M13 as an Ideal Anchor for Gold
  20. Nanocubes. ACS synthetic biology. 2017; 6(9):1635-1641. PubMed [journal] PMID: